Pericardial Drain Removal Safe Following Cardiac Tamponade
|
By Daniel Beris Posted on 14 Dec 2016 |
After treating cardiac tamponade arising from atrial fibrillation (AF) catheter ablation, pericardial drains do not need to be kept in place for an additional day, according to a new study.
Researchers at John Radcliffe Hospital (Oxford, United Kingdom) conducted a retrospective descriptive analysis study of 43 cases of cardiac tamponade resulting from complication of atrial fibrillation catheter ablation (AFCA) procedures between 2006 and 2015 in order to examine the safety of early removal of pericardial drains. The researcher compared 25 patients in whom the drain was removed early to 18 patients who underwent traditional delayed removal. Cardiac tamponade was diagnosed when pericardial effusion led to hypoperfusion and systolic blood pressure dropped below 80 mm Hg.
In cases that employed early removal strategy, the pericardial space was monitored for reaccumulation for a minimum of 30 minutes, with repeated transthoracic echocardiography. Once it reached dryness, the patient was deemed ready to leave the laboratory and the drain was left to operator discretion for removal. The delayed removal group was monitored for an extra 17 hours once no reaccumulation was confirmed. The main outcomes included need for repeat pericardiocentesis, major adverse outcomes, length of stay, and need for opiate analgesia.
The results showed that not one of the AF patients who had the drains taken out early needed repeat pericardiocentesis before hospital discharge. They also had a moderately shorter length of stay than their peers who had drain removal delayed in case of re-bleeding, and also went back on anticoagulation earlier. In addition, few patients with early removal needed opiate analgesia (8%) compared to the delayed removal group (72%). The study was published on November 15, 2016, in JACC: Clinical Electrophysiology.
“Early removal of pericardial drains after tamponade complicating atrial fibrillation catheter ablation procedures appears to be safe and effective, with re-insertion not required in this cohort,” concluded lead author Michala Pedersen, MD, and colleagues. “The traditional practice of leaving drains in situ for 12 to 24 hours may result in more patient discomfort and longer hospitalization. Additionally, there may be benefits to health economics.”
Cardiac tamponade occurs when fluid in the pericardium accumulates, resulting in compression of the heart. Symptoms typically include shortness of breath, weakness, lightheadedness, and cough. If fluid increases slowly the pericardial sac can expand to contain more than two liters; however, if the increase is rapid, as little as 200 mL can result in tamponade. When tamponade results in symptoms, drainage is necessary, by pericardiocentesis, a pericardial window, or a pericardiectomy. Tamponade due to AFCA is traditionally managed by pericardiocentesis with delayed removal of the drain (typically 12 to 24 hours later) in case of re-bleeding.
Related Links:
John Radcliffe Hospital
Researchers at John Radcliffe Hospital (Oxford, United Kingdom) conducted a retrospective descriptive analysis study of 43 cases of cardiac tamponade resulting from complication of atrial fibrillation catheter ablation (AFCA) procedures between 2006 and 2015 in order to examine the safety of early removal of pericardial drains. The researcher compared 25 patients in whom the drain was removed early to 18 patients who underwent traditional delayed removal. Cardiac tamponade was diagnosed when pericardial effusion led to hypoperfusion and systolic blood pressure dropped below 80 mm Hg.
In cases that employed early removal strategy, the pericardial space was monitored for reaccumulation for a minimum of 30 minutes, with repeated transthoracic echocardiography. Once it reached dryness, the patient was deemed ready to leave the laboratory and the drain was left to operator discretion for removal. The delayed removal group was monitored for an extra 17 hours once no reaccumulation was confirmed. The main outcomes included need for repeat pericardiocentesis, major adverse outcomes, length of stay, and need for opiate analgesia.
The results showed that not one of the AF patients who had the drains taken out early needed repeat pericardiocentesis before hospital discharge. They also had a moderately shorter length of stay than their peers who had drain removal delayed in case of re-bleeding, and also went back on anticoagulation earlier. In addition, few patients with early removal needed opiate analgesia (8%) compared to the delayed removal group (72%). The study was published on November 15, 2016, in JACC: Clinical Electrophysiology.
“Early removal of pericardial drains after tamponade complicating atrial fibrillation catheter ablation procedures appears to be safe and effective, with re-insertion not required in this cohort,” concluded lead author Michala Pedersen, MD, and colleagues. “The traditional practice of leaving drains in situ for 12 to 24 hours may result in more patient discomfort and longer hospitalization. Additionally, there may be benefits to health economics.”
Cardiac tamponade occurs when fluid in the pericardium accumulates, resulting in compression of the heart. Symptoms typically include shortness of breath, weakness, lightheadedness, and cough. If fluid increases slowly the pericardial sac can expand to contain more than two liters; however, if the increase is rapid, as little as 200 mL can result in tamponade. When tamponade results in symptoms, drainage is necessary, by pericardiocentesis, a pericardial window, or a pericardiectomy. Tamponade due to AFCA is traditionally managed by pericardiocentesis with delayed removal of the drain (typically 12 to 24 hours later) in case of re-bleeding.
Related Links:
John Radcliffe Hospital
Latest Surgical Techniques News
- Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
- New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
- Robot-Assisted Brain Angiography Improves Procedural Outcomes
- Brain Mapping Technology Enhances Precision in Brain Tumor Resection
- Handheld Robotic System Expands Options for Total Knee Surgery
- VR Experience Reduces Patient Anxiety Before Kidney Stone Procedure
- Injectable Mini Livers Offer Hope for Patients Awaiting Transplant
- Pulsed Field Ablation Technology Cleared in Europe for Persistent AFib
- AI-Powered Imaging Brings Real-Time Margin Clarity to Breast Cancer Surgery
- Minimally Invasive Device Safely Treats Challenging Brain Aneurysms
- Surgical Robot Makes Complex Liver Tumor Surgery Safer and Less Invasive
- Neurostimulation Implant Reduces Seizure Burden in Drug-Resistant Epilepsy
- Minimally Invasive Procedure Effectively Treats Small Kidney Cancers
- Fluorescence Probe Paired with Engineered Enzymes Lights Up Tumors for Easier Surgical Removal
- Novel Hydrogel Could Become Bone Implant of the Future
- Skull Implant Design Could Shape Surgical Outcomes
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read moreCritical Care
view channel
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read more
First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
Pulmonary hypertension is a progressive, life‑threatening disease that is frequently missed early because symptoms such as dyspnea are nonspecific and diagnostic delays can exceed two years.... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel







